Partners Capital Investment Group’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $183K | Sell |
161,597
-93,248
| -37% | -$105K | 0.01% | 158 |
|
|
2025
Q1 | $372K | Buy |
254,845
+161,597
| +173% | +$236K | 0.01% | 159 |
|
|
2024
Q4 | $199K | Sell |
93,248
-161,597
| -63% | -$344K | 0.01% | 124 |
|
|
2024
Q3 | $714K | Sell |
254,845
-200,000
| -44% | -$560K | 0.01% | 144 |
|
|
2024
Q2 | $1.07M | Buy |
454,845
+361,597
| +388% | +$851K | 0.02% | 143 |
|
|
2024
Q1 | $417K | Sell |
93,248
-361,597
| -79% | -$1.62M | 0.01% | 136 |
|
|
2023
Q4 | $1.46M | Hold |
454,845
| – | – | 0.03% | 129 |
|
|
2023
Q3 | $1.44M | Hold |
454,845
| – | – | 0.03% | 129 |
|
|
2023
Q2 | $2.26M | Buy |
454,845
+361,597
| +388% | +$1.8M | 0.05% | 125 |
|
|
2023
Q1 | $461K | Hold |
93,248
| – | – | 0.02% | 111 |
|
|
2022
Q4 | $587K | Hold |
93,248
| – | – | 0.03% | 112 |
|
|
2022
Q3 | $1.01M | Hold |
93,248
| – | – | 0.06% | 105 |
|
|
2022
Q2 | $1.06M | Hold |
93,248
| – | – | 0.07% | 93 |
|
|
2022
Q1 | $849K | Hold |
93,248
| – | – | 0.04% | 101 |
|
|
2021
Q4 | $1.39M | Hold |
93,248
| – | – | 0.06% | 97 |
|
|
2021
Q3 | $2.4M | Hold |
93,248
| – | – | 0.11% | 86 |
|
|
2021
Q2 | $2.43M | Sell |
93,248
-12,506
| -12% | -$326K | 0.11% | 100 |
|
|
2021
Q1 | $3.73M | Sell |
105,754
-25,012
| -19% | -$883K | 0.16% | 85 |
|
|
2020
Q4 | $3.3M | Sell |
130,766
-6,253
| -5% | -$158K | 0.19% | 76 |
|
|
2020
Q3 | $5.17M | Sell |
137,019
-11,645
| -8% | -$439K | 0.32% | 61 |
|
|
2020
Q2 | $6.37M | Sell |
148,664
-18,326
| -11% | -$785K | 0.31% | 59 |
|
|
2020
Q1 | $3.25M | Sell |
166,990
-16,760
| -9% | -$326K | 0.22% | 65 |
|
|
2019
Q4 | $4.77M | Buy |
+183,750
| New | +$4.77M | 0.36% | 59 |
|